Craft

ResMed

Stock Price

$256.1

2024-10-25

Market Capitalization

$37.6 B

2024-10-25

Revenue

$4.7 B

FY, 2024

ResMed Summary

Company Summary

Overview
ResMed is a company that specializes in digital health and cloud-connected medical devices. It operates in two segments: the Sleep and Respiratory Care segment and the Software as a Service (SaaS). The company develops, manufactures, and distributes medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.
Type
Public
Status
Active
Founded
1994
HQ
San Diego, CA, US | view all locations
Website
https://investor.resmed.com/
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Michael Mick Farrell

    Michael Mick Farrell, CEO

    • Rob Douglas

      Rob Douglas, President and Chief Operating Officer

    • David Pendarvis

      David Pendarvis, Chief Administrative Officer, Global General Counsel

    • Jim Hollingshead

      Jim Hollingshead, President, Sleep Business

    Operating MetricsView all

    Patents (US)

    619
    9.6%

    FY, 2023

    Patents Pending

    9.7K
    6.6%

    FY, 2023

    Patents (Foreign)

    1.5K
    2.6%

    FY, 2023

    LocationsView all

    30 locations detected

    • San Diego, CA HQ

      United States

      9001 Spectrum Center Blvd

    • Bella Vista, New South Wales

      Australia

      1 Elizabeth Macarthur Dr

    • Bruxelles, Bruxelles

      Belgium

      Av. du Boulevard 21

    • São Paulo, SP

      Brazil

      Roque Petroni Junior Avenue, 850 Bacaetava Tower

    • Beijing, Bei Jing Shi

      China

      Tai Yang Gong Zhong Lu, Chao Yang Qu

    • Maribo

      Denmark

      Kidnakken 11

    and 24 others

    ResMed Financials

    Summary Financials

    Revenue (Q1, 2025)
    $1.2B
    Gross profit (Q1, 2025)
    $717.2M
    Net income (Q1, 2025)
    $311.4M
    Cash (Q1, 2025)
    $426.4M
    EBIT (Q1, 2025)
    $387.3M
    Enterprise value
    $37.8B

    Footer menu